Choline transporters, cholinergic transmission and cognition

Cholinergic projections to the cortex and hippocampus mediate fundamental cognitive processes. The capacity of the high-affinity choline uptake transporter (CHT) to import choline from the extracellular space to presynaptic terminals is essential for normal acetylcholine synthesis and therefore cholinergic transmission. The CHT is highly regulated, and the cellular mechanisms that modulate its capacity show considerable plasticity. Recent evidence links changes in CHT capacity with the ability to perform tasks that tax attentional processes and capacities. Abnormal regulation of CHT capacity might contribute to the cognitive impairments that are associated with neurodegenerative and neuropsychiatric disorders. Therefore, the CHT might represent a productive target for the development of new pharmacological treatments for these conditions.

[1]  P. Bushnell,et al.  Signal detection behavior in humans and rats: a comparison with matched tasks , 2003, Behavioural Processes.

[2]  T. Haga,et al.  Distribution of the high-affinity choline transporter in the central nervous system of the rat , 2001, Neuroscience.

[3]  C. Nemeroff,et al.  Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies. , 1994, The Journal of clinical investigation.

[4]  M. Sarter,et al.  Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. , 1996, Behavioral neuroscience.

[5]  R. Wurtman,et al.  Choline production from choline-containing phospholipids: A hypothetical role in Alzheimer's disease and aging , 1984, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[6]  J. Hagan,et al.  Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics , 2004, Psychopharmacology.

[7]  L. Hersh,et al.  Prefrontal cortical projections to the cholinergic neurons in the basal forebrain , 1991, The Journal of comparative neurology.

[8]  E. Cochran,et al.  Down‐regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease , 2001, The Journal of comparative neurology.

[9]  R. Jaffard,et al.  The durations of hippocampal and cortical cholinergic activation induced by spatial discrimination testing of mice in an eight-arm radial maze decrease as a function of acquisition. , 1989, Behavioral and neural biology.

[10]  J. Tapia,et al.  Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Kuhar.  Sodium-dependent high affinity choline uptake. , 1979, Progress in brain research.

[12]  M. Kuhar,et al.  SODIUM‐DEPENDENT HIGH AFFINITY CHOLINE UPTAKE: A REGULATORY STEP IN THE SYNTHESIS OF ACETYLCHOLINE , 1976, Journal of neurochemistry.

[13]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[14]  Michael E. Hasselmo,et al.  Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection , 2005, Brain Research Reviews.

[15]  A. Levey,et al.  Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system , 2003, The Journal of comparative neurology.

[16]  J. Coyle,et al.  Rapid in vitro modulation of [3H]hemicholinium-3 binding sites in rat striatal slices. , 1987, European journal of pharmacology.

[17]  Takashi Okuda,et al.  Single Nucleotide Polymorphism of the Human High Affinity Choline Transporter Alters Transport Rate* , 2002, The Journal of Biological Chemistry.

[18]  M. Mesulam.  The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? , 2004, Learning & memory.

[19]  E. Cochran,et al.  Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease , 2000, The Journal of comparative neurology.

[20]  Randy D Blakely,et al.  The choline transporter resurfaces: new roles for synaptic vesicles? , 2004, Molecular interventions.

[21]  M. Sarter,et al.  Differential cortical acetylcholine release in rats performing a sustained attention task versus behavioral control tasks that do not explicitly tax attention , 2002, Neuroscience.

[22]  R. Quirion,et al.  Amyloid β‐Peptide Inhibits High‐Affinity Choline Uptake and Acetylcholine Release in Rat Hippocampal Slices , 1998 .

[23]  Rémi Quirion,et al.  Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post‐pubertal rats with neonatal ventral hippocampal lesions , 2004, Journal of neurochemistry.

[24]  Adolf Pfefferbaum,et al.  The Human Basal Forebrain Integrates the Old and the New , 2004, Neuron.

[25]  M. Sarter,et al.  Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. , 1997, Brain research. Cognitive brain research.

[26]  P. Thompson,et al.  Neurobiology of intelligence: science and ethics , 2004, Nature Reviews Neuroscience.

[27]  D. Drachman,et al.  Memory and cognitive function in man , 1977, Neurology.

[28]  Steven T. DeKosky,et al.  Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction , 2003, Journal of Chemical Neuroanatomy.

[29]  J. Reasor,et al.  Chronic ethanol ingestion produces cholinergic hypofunction in rat brain. , 1997, Alcohol.

[30]  M. Hasselmo,et al.  High acetylcholine levels set circuit dynamics for attention and encoding and low acetylcholine levels set dynamics for consolidation. , 2004, Progress in brain research.

[31]  Jun Xie,et al.  Par-4 Inhibits Choline Uptake by Interacting with CHT1 and Reducing Its Incorporation on the Plasma Membrane* , 2004, Journal of Biological Chemistry.

[32]  J. Changeux,et al.  Enhanced Hemicholinium Binding and Attenuated Dendrite Branching in Cognitively Impaired Acetylcholinesterase‐Transgenic Mice , 1997, Journal of neurochemistry.

[33]  K. Lesch,et al.  The human serotonin transporter gene polymorphism-basic research and clinical implications , 2005, Journal of Neural Transmission.

[34]  M. Sarter,et al.  Sustained Visual Attention Performance-Associated Prefrontal Neuronal Activity: Evidence for Cholinergic Modulation , 2000, The Journal of Neuroscience.

[35]  J. Blusztajn,et al.  Choline, a Vital Amine , 1998, Science.

[36]  G. Gerhardt,et al.  Rapid assessment of in vivo cholinergic transmission by amperometric detection of changes in extracellular choline levels , 2004, The European journal of neuroscience.

[37]  T. Durkin.  Spatial working memory over long retention intervals: Dependence on sustained cholinergic activation in the septohippocampal or nucleus basalis magnocellularis-cortical pathways? , 1994, Neuroscience.

[38]  A. Beley,et al.  Involvement of cAMP in the regulation of high affinity choline uptake by rat brain synaptosomes. , 1995, Biochemical and Biophysical Research Communications - BBRC.

[39]  J A Deutsch,et al.  The Cholinergic Synapse and the Site of Memory , 1971, Science.

[40]  J. Coyle,et al.  The role of calcium in the regulation of [3H]hemicholinium-3 binding sites in rat brain , 1988, Neuropharmacology.

[41]  L. Záborszky.  The modular organization of brain systems. Basal forebrain: the last frontier. , 2002, Progress in brain research.

[42]  A. Popp,et al.  Central cholinergic functions in human amyloid precursor protein knock-in/presenilin-1 transgenic mice , 2004, Neuroscience.

[43]  Raja Parasuraman,et al.  Varieties of attention , 1984 .

[44]  H. Dingle,et al.  Science and Ethics , 1946, Nature.

[45]  T. Okuda,et al.  Ultrastructural localization of high‐affinity choline transporter in the rat neuromuscular junction: Enrichment on synaptic vesicles , 2004, Synapse.

[46]  M. Sarter,et al.  Cognitive functions of cortical acetylcholine: toward a unifying hypothesis , 1997, Brain Research Reviews.

[47]  R. Wurtman,et al.  Effect of oral CDP-choline on plasma choline and uridine levels in humans. , 2000, Biochemical pharmacology.

[48]  M. Sarter,et al.  Repeated pretreatment with amphetamine sensitizes increases in cortical acetylcholine release , 2000, Psychopharmacology.

[49]  M. Posner,et al.  Attentional networks , 1994, Trends in Neurosciences.

[50]  Bernard E. Rollin,et al.  Science and Ethics , 1943, Nature.

[51]  Randy D Blakely,et al.  Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. , 2003, Molecular pharmacology.

[52]  S. Stahl.  Neurotransmission of cognition, part 3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in prefrontal cortex. , 1899, The Journal of clinical psychiatry.

[53]  R. Wurtman.  Choline metabolism as a basis for the selective vulnerability of cholinergic neurons , 1992, Trends in Neurosciences.

[54]  Greg A. Gerhardt,et al.  Ceramic-based multisite microelectrode arrays for in vivo electrochemical recordings of glutamate and other neurochemicals , 2003 .

[55]  M. Mattson,et al.  Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease , 1998, Nature Medicine.

[56]  F. Gage,et al.  Choline Transporter 1 Maintains Cholinergic Function in Choline Acetyltransferase Haploinsufficiency , 2004, The Journal of Neuroscience.

[57]  Douglas W. Jones,et al.  In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. , 2003, The American journal of psychiatry.

[58]  H. Moore,et al.  Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release , 1999, Neuroscience.

[59]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[60]  G. Gerhardt,et al.  Ceramic-based multisite microelectrode array for rapid choline measures in brain tissue , 2003 .

[61]  T. Hyde,et al.  Cholinergic systems and schizophrenia: primary pathology or epiphenomena? , 2001, Journal of Chemical Neuroanatomy.

[62]  Tor D Wager,et al.  Neuroimaging studies of shifting attention: a meta-analysis , 2004, NeuroImage.

[63]  N. Weinberger.  Specific long-term memory traces in primary auditory cortex , 2004, Nature Reviews Neuroscience.

[64]  W. James,et al.  The Principles of Psychology. , 1983 .

[65]  S. Leurgans,et al.  Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.

[66]  M. Posner,et al.  The attention system of the human brain. , 1990, Annual review of neuroscience.

[67]  A. Levey,et al.  Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters , 2003, The Journal of Neuroscience.

[68]  D. Olton,et al.  Behavior alters the uptake of [3h]choline into acetylcholinergic neurons of the nucleus basalis magnocellularis and medial septal area , 1984, Behavioural Brain Research.

[69]  M. Gallagher,et al.  Effects of training on a spatial memory task on high affinity choline uptake in hippocampus and cortex in young adult and aged rats , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  Martin Sarter,et al.  Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities , 2004, Neurobiology of Aging.

[71]  J. Haxby,et al.  Cholinergic enhancement and increased selectivity of perceptual processing during working memory. , 2000, Science.

[72]  M. Kuhar,et al.  Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. , 1975, Life sciences.

[73]  C. Nemeroff,et al.  Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[74]  P. Lockman,et al.  The Transport of Choline , 2002, Drug development and industrial pharmacy.

[75]  J. Edeline.  The thalamo-cortical auditory receptive fields: regulation by the states of vigilance, learning and the neuromodulatory systems , 2003, Experimental Brain Research.

[76]  A. Nuñez,et al.  Electrophysiological evidence for the existence of a posterior cortical–prefrontal–basal forebrain circuitry in modulating sensory responses in visual and somatosensory rat cortical areas , 2003, Neuroscience.

[77]  Martin Sarter,et al.  Lateralized attentional functions of cortical cholinergic inputs. , 2004, Behavioral neuroscience.

[78]  Takashi Okuda,et al.  Identification and characterization of the high-affinity choline transporter , 2000, Nature Neuroscience.

[79]  E. Stein,et al.  Multiple Neuronal Networks Mediate Sustained Attention , 2003, Journal of Cognitive Neuroscience.

[80]  S. Ferguson,et al.  The hemicholinium‐3 sensitive high affinity choline transporter is internalized by clathrin‐mediated endocytosis and is present in endosomes and synaptic vesicles , 2003, Journal of neurochemistry.

[81]  M. Sarter,et al.  Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory? , 2003, Neurobiology of Learning and Memory.

[82]  T. Robbins,et al.  The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry , 2002, Psychopharmacology.

[83]  K. Moxon,et al.  Ceramic-based multisite microelectrodes for electrochemical recordings. , 2000, Analytical chemistry.

[84]  Patrik Vuilleumier,et al.  Cholinergic enhancement modulates neural correlates of selective attention and emotional processing , 2003, NeuroImage.

[85]  M. Knipper,et al.  Regulation of hemicholinium binding sites in isolated nerve terminals. , 1992, Journal of neurobiology.

[86]  Yu-Shin Ding,et al.  Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer’s dementia , 2001, Biological Psychiatry.

[87]  R. Blakely,et al.  Regulation of Choline Transporter Surface Expression and Phosphorylation by Protein Kinase C and Protein Phosphatase 1/2A , 2004, Journal of Pharmacology and Experimental Therapeutics.

[88]  S. Kéri,et al.  Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[89]  H. Yamamura,et al.  Sodium-dependent high-affinity binding of [3H]hemicholinium-3 in the rat brain: a potentially selective marker for presynaptic cholinergic sites. , 1984, Life sciences.

[90]  M. Sarter,et al.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands , 1995, Psychopharmacology.

[91]  M. Raichle,et al.  Localization of a human system for sustained attention by positron emission tomography , 1991, Nature.

[92]  L. Flicker,et al.  Lecithin for dementia and cognitive impairment. , 2000, The Cochrane database of systematic reviews.

[93]  T. Robbins,et al.  Distinct Changes in Cortical Acetylcholine and Noradrenaline Efflux during Contingent and Noncontingent Performance of a Visual Attentional Task , 2001, The Journal of Neuroscience.

[94]  R. Blakely,et al.  Molecular cloning of a human, hemicholinium-3-sensitive choline transporter. , 2000, Biochemical and biophysical research communications.